Search

everythinglearnresearchcommunity

for

Search:↓

Understanding both skin and mental health aspects of alopecia areata is crucial for better patient care.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

The FUL hair restoration technique is better for aesthetics and causes less scarring.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

New treatments like JAK inhibitors offer hope for hair regrowth in severe alopecia areata.

Early intervention and patient education are crucial for managing alopecia areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Psychological factors significantly impact alopecia areata.

Alopecia areata causes hair loss and has various treatment options, but responses differ.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Ketoconazole effectively treated a scalp infection in a 6-year-old boy, leading to full recovery.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Low vitamin D levels are linked to severe and active alopecia areata.

The document doesn't say if the treatment for hair loss worked.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

The best concentration of triamcinolone acetonide for treating alopecia areata is still unclear.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

Methotrexate and azathioprine can help treat alopecia areata.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

The conclusion is that common non-infectious scalp diseases often have similar symptoms, making diagnosis challenging.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.